{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:13:01Z","timestamp":1785607981854,"version":"3.56.0"},"reference-count":18,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Technology &amp; Therapeutics"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>We describe the utilization of telemedicine visits (video or telephone) across the type 1 diabetes (T1D) Exchange Quality Improvement Collaborative (T1DX-QI) during the COVID-19 pandemic. Metrics, site-level survey results, and examples of interventions conducted to support telemedicine in T1D are shown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Thirteen clinics (11 pediatric, 2 adult) provided monthly telemedicine metrics between December 2019 and August 2020 and 21 clinics completed a survey about their telemedicine practices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The proportion of telemedicine visits in T1DX-QI before the pandemic was &lt;1%, rising to an average of 95.2% in April 2020 (range 52.3%\u201399.5%). Three sites initially used mostly telephone visits before converting to video visits. By August 2020, the proportion of telemedicine visits decreased to an average of 45% across T1DX-QI (range 10%\u201386.6%). The majority of clinics (62%) performed both video and telephone visits; Zoom was the most popular video platform used. Over 95% of clinics reported using CareLink\u2122, Clarity\n                      <jats:sup>\u00ae<\/jats:sup>\n                      , Glooko\u2122, and\/or t:connect\n                      <jats:sup>\u00ae<\/jats:sup>\n                      to view device data, with only one center reporting automated data upload into the electronic medical record. The majority of centers had multidisciplinary teams participating in the video visits. All sites reported reimbursement for video visits, and 95% of sites reported coverage for telephone visits early on in the pandemic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>There was rapid adoption of telemedicine in T1DX-QI during the COVID-19 pandemic. Future insurance reimbursement for telemedicine visits and the ideal ratio of telemedicine to in-person visits in T1D care remain to be determined.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/dia.2021.0080","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T15:59:15Z","timestamp":1618415955000},"page":"642-651","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":67,"title":["Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic"],"prefix":"10.1177","volume":"23","author":[{"given":"Joyce M.","family":"Lee","sequence":"first","affiliation":[{"name":"C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Carlson","sequence":"additional","affiliation":[{"name":"T1D Exchange, Boston, Massachusetts, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Albanese-O'Neill","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville, Florida, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Demeterco-Berggren","sequence":"additional","affiliation":[{"name":"Rady Children's Hospital\/University of California, San Diego, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah D.","family":"Corathers","sequence":"additional","affiliation":[{"name":"Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vendrame","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine, Miami, Florida, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-5666","authenticated-orcid":false,"given":"Ruth S.","family":"Weinstock","sequence":"additional","affiliation":[{"name":"SUNY Upstate Medical University, Syracuse, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Prahalad","sequence":"additional","affiliation":[{"name":"Lucile Packard Children's Hospital\/Stanford University, Palo Alto, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-761X","authenticated-orcid":false,"given":"Guy Todd","family":"Alonso","sequence":"additional","affiliation":[{"name":"Barbara Davis Center, University of Colorado, Aurora, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmohan","family":"Kamboj","sequence":"additional","affiliation":[{"name":"Nationwide Children's Hospital, Columbus, Ohio, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"DeSalvo","sequence":"additional","affiliation":[{"name":"Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal S.","family":"Malik","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle, Washington, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Izquierdo","sequence":"additional","affiliation":[{"name":"SUNY Upstate Medical University, Syracuse, New York, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8473-249X","authenticated-orcid":false,"given":"Osagie","family":"Ebekozien","sequence":"additional","affiliation":[{"name":"T1D Exchange, Boston, Massachusetts, USA."},{"name":"Bower School of Population Health, University of Mississippi Medical Center, Jackson, Mississippi, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150885"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0098"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0450"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0739"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X17700552"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X17704346"},{"key":"e_1_3_5_8_2","article-title":"Evaluation of the clinical outcomes of telehealth for managing diabetes: a PRISMA-compliant meta-analysis","volume":"97","author":"Wu C","year":"2018","unstructured":"Wu C, , Wu Z, , Yang L, et al.: Evaluation of the clinical outcomes of telehealth for managing diabetes: a PRISMA-compliant meta-analysis. Medicine (Baltimore), 2018; 97:e12962.","journal-title":"Medicine (Baltimore)"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/1357633X16674087"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2020.0161"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13180"},{"key":"e_1_3_5_12_2","unstructured":"Weigel G Ramaswamy A Sobel L et al.: Opportunities and barriers for telemedicine in the U.S. During the COVID-19 emergency and beyond. 2020. https:\/\/www.kff.org\/womens-health-policy\/issue-brief\/opportunities-and-barriers-for-telemedicine-in-the-u-s-during-the-covid-19-emergency-and-beyond (accessed December10 2020)."},{"key":"e_1_3_5_13_2","unstructured":"Centers for Medicare & Medicaid Services (CMS): Medicare Telemedicine Health Care Provider Fact Sheet: https:\/\/www.cms.gov\/newsroom\/fact-sheets\/medicare-telemedicine-health-care-provider-fact-sheet (accessed December10 2020)."},{"key":"e_1_3_5_14_2","unstructured":"Health and Human Services (HHS): OCR announces notification of enforcement discretion for telehealth remote communications during the COVID-19 nationwide public health emergency. https:\/\/www.hhs.gov\/about\/news\/2020\/03\/17\/ocr-announces-notification-of-enforcement-discretion-for-telehealth-remote-communications-during-the-covid-19.html# (accessed December10 2020)."},{"key":"e_1_3_5_15_2","unstructured":"Centers for Medicare & Medicaid Services (CMS): Trump administration issues second round of sweeping changes to support U.S. Healthcare System during COVID-19 pandemic: https:\/\/www.cms.gov\/newsroom\/press-releases\/trump-administration-issues-second-round-sweeping-changes-support-us-healthcare-system-during-covid (accessed December10 2020)."},{"key":"e_1_3_5_16_2","unstructured":"Centers for Medicare & Medicaid Services (CMS): Covered Telehealth Services for PHE for the COVID-19 pandemic effective March 1 2020. https:\/\/www.cms.gov\/Medicare\/Medicare-General-Information\/Telehealth\/Telehealth-Codes (accessed January14 2021)."},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05034-1"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2020-000985"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.12788\/jcom.0031"}],"container-title":["Diabetes Technology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dia.2021.0080","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2021.0080","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dia.2021.0080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:13:07Z","timestamp":1777399987000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/dia.2021.0080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1089\/dia.2021.0080"],"URL":"https:\/\/doi.org\/10.1089\/dia.2021.0080","relation":{},"ISSN":["1520-9156","1557-8593"],"issn-type":[{"value":"1520-9156","type":"print"},{"value":"1557-8593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}